#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital leptin deficiency Von Willebrand's disease Hereditary spastic paraplegia Neuroendocrine carcinoma of the skin Prader-Willi syndrome Hereditary motor and sensory neuropathy Noonan syndrome Cardiac failure acute Thyroid cancer metastatic Neuroendocrine carcinoma metastatic Wolfram syndrome Retinal dystrophy Prolymphocytic leukaemia Chondrosarcoma Philadelphia chromosome positive More trials…

    Learn about Rare Diseases

    Glycogen storage disease type I Chordoma – Diagnostics Ewing’s sarcoma recurrent – Basic Information Rett syndrome – Life with Disease Paraneoplastic neurological syndrome – Treatment Pelizaeus-Merzbacher disease – Trials in Disease Hepatoblastoma – Treatment Haemophilia A with anti factor VIII Lymphangiosarcoma – Life with Disease Hyperoxaluria – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Corline Heparin Conjugate Erythromycin Quinine Dihydrochloride ANUMIGILIMAB ULVIPRUBART Gs-5718-03 Insulin Lispro [18F]Alf-Nota-Octreotide Chlorhexidine Dihydrochloride Rgx-202 10-1074-Ls AZD1163 Cimetidine Levonorgestrel Acetylsalicylic Acid Remifentanil Betula Pendula Pollen Extract Inotuzumab Ozogamicin Savolitinib Apixaban More therapies…

    Learn about Your Condition

    Merycism H1N1 influenza Erectile dysfunction Mitochondrial DNA depletion Post procedural hypotension Epidermolysis bullosa Marginal zone lymphoma Rectal cancer Mixed-type liposarcoma Mental disorder Retinitis pigmentosa Kearns-Sayre syndrome Myocarditis Coronary artery disease Takayasu's arteritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. EVAGGELISMOS”General Hospital of Athens

EVAGGELISMOS”General Hospital of Athens

Ipsiladou 45-47, Athens, 106 76, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Cevostamab, Pomalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma Previously Treated with 1‑3 Lines of Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Cevostamab
    • Carfilzomib
    • Daratumumab
    Czechia Denmark France Germany Greece Italy +2

  • Long-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Nilotinib
    • Asciminib Hydrochloride
    • Imatinib
    Austria Bulgaria Czechia Denmark France Germany +8

  • Long-Term Study of Imeroprubart in Adults With Graves’ Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Graves’ disease
    Investigated Drugs:
    • IMEROPRUBART
    Belgium Bulgaria Czechia Germany Greece Hungary +5

  • A study of the safety and effectiveness of REGN17372 and linvoseltamab in adults with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Linvoseltamab
    • Dexamethasone
    • Diphenhydramine Hydrochloride
    Greece

  • A Study of Gilteritinib to Eliminate Remaining Cancer Cells in Patients with Acute Myeloid Leukemia and FLT3-ITD Mutation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Gilteritinib
    Greece

  • Study of IMVT-1402 Treatment for Adults with Graves’ Disease

    Recruiting

    2 1
    Investigated Drugs:
    • IMEROPRUBART
    Bulgaria Czechia Germany Greece Italy Latvia +3

  • Study of mezigdomide and elranatamab combination treatment for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Elranatamab
    • Dexamethasone
    • Mezigdomide
    Germany Greece Norway Spain

  • Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hypertension
    • Type 2 diabetes mellitus
    • Cardiovascular disorder
    Investigated Drugs:
    • Bi 690517
    • Empagliflozin
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Study of Bleximenib, Venetoclax, and Azacitidine Treatment for Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Azacitidine
    • BLEXIMENIB
    • Venetoclax
    Austria Belgium Czechia Denmark France Germany +6

  • Study Comparing Golcadomide and Rituximab with Other Treatments for Patients with Relapsed or Refractory Follicular Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Golcadomide
    • Bendamustine Hydrochloride
    • Betamethasone Sodium Phosphate
    Finland France Germany Greece Italy The Netherlands +2
1 2 3 … 6
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!